Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26F1J28
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,492
Award facts
- Contract value 100% obligated
- $9,492.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for supply of RINVOQ ER 15 mg tablets (30-count unit dose) with a ceiling value of $9,492.44. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and carries an ultimate completion date of November 19, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical vendor supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's extensive portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. RINVOQ ER is a JAK inhibitor used in the treatment of rheumatoid arthritis and other inflammatory conditions, representing the type of specialty pharmaceutical product the company routinely supplies to federal healthcare programs. AmerisourceBergen's consistent success in competitively awarded federal contracts demonstrates its capability to meet procurement requirements across varying order values and medical product categories.
Quick answers
Who was awarded contract SPE2DR26F1J28?
SPE2DR26F1J28 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26F1J28 worth?
The government has obligated $9,492 on SPE2DR26F1J28.
Is contract SPE2DR26F1J28 an order under another contract?
Yes. SPE2DR26F1J28 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1J28 competed?
The extent of competition for SPE2DR26F1J28 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award